Clinical Trial Update: Standard Chemotherapy Followed by Capecitabine as Prolonged Postoperative Adjuvant Treatment for Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update in breast cancer evaluating prolonged postoperative adjuvant therapy with capecitabine after standard chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN